Stem cell therapy in stroke: A review literature

International Journal of Preventive Medicine

Volumn 4, Issue , 2013, Pages S139-S146

  Meamar, Rokhsareh ^a,b   Dehghani, Leila ^b   Ghasemi, Majid ^a   Khorvash, Fariborz ^a   Shaygannejad, Vahid ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Clinical; Stem cell; Stroke; Treatment; Trials

Indexed keywords

CELL LINE; CELL THERAPY; CELLS BY BODY ANATOMY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); EMBRYONIC STEM CELL; HUMAN; INTERMETHOD COMPARISON; MENSTRUAL BLOOD; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REPAIR;

EID: 84886751016     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 2006;441:1094-6.
2. Banerjee S, Williamson D, Habib N, Gordon M, Chataway J. Human stem cell therapy in ischaemic stroke: A review. Age Ageing 2011;40:7-13.
3. Abe K, Kogure K. Selective gene expression after brain ischemia. Prog Brain Res 1993;96:221-36.
4. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-711.
5. Hess DC, Borlongan CV. Cell-based therapy in ischemic stroke. Expert Rev Neurother 2008;8:1193-201.
6. Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, Strazzer S, et al. Stem cell therapy in stroke. Cell Mol Life Sci 2009;66:757-72.
7. Abe K, Yamashita T, Takizawa S, Kuroda S, Kinouchi H, Kawahara N. Stem cell therapy for cerebral ischemia: From basic science to clinical applications. J Cereb Blood Flow Metab 2012;32:1317-31.
8. Bliss TM, Andres RH, Steinberg GK. Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 2010;37:275-83.
9. Lindvall O, Kokaia Z. Stem cell research in stroke: How far from the clinic? Stroke 2011;42:2369-75.
10. Muthaian R, Minhas G, Anand A. Pathophysiology of stroke and stroke-induced retinal ischemia: Emerging role of stem cells. J Cell Physiol 2012;227:1269-79.
11. Smith HK, Gavins FN. The potential of stem cell therapy for stroke: Is PISCES the sign? FASEB J 2012;26:2239-52.
12. Burns TC, Steinberg GK. Stem cells and stroke: Opportunities, challenges and strategies. Expert Opin Biol Ther 2011;11:447-61.
13. Alvarez-Buylla A, Garcia-Verdugo JM. Neurogenesis in adult subventricular zone. J Neurosci 2005;22:629-34.
14. Gage FH. Mammalian neural stem cells. Science 2000;287:1433-8.
15. Bühnemann C, Scholz A, Bernreuther C, Malik CY, Braun H, Schachner M, et al. Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats. Brain 2006;129:3238-48.
16. Shyu WC, Lin SZ, Yang HI, Tzeng YS, Pang CY, Yen PS, et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004;110:1847-54.
17. Schäbitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Schölzke MN, et al. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003;34:745-51.
18. Sprigg N, Bath PM, Zhao L, Willmot MR, Gray LJ, Walker MF, et al. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: The Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke 2006;37:2979-83.
19. Shyu WC, Lin SZ, Lee CC, Liu DD, Li H. Granulocyte colony-stimulating factor for acute ischemic stroke: A randomized controlled trial. CMAJ 2006;174:927-33.
20. Bath PM, Sprigg N. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database Syst Rev 2007;(2):CD005207.
21. Schäbitz WR, Schneider A. Developing granulocyte-colony stimulating factor for the treatment of stroke: Current status of clinical trials. Stroke 2006;37:1654.
22. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7.
23. Daadi MM, Maag AL, Steinberg GK. Adherent self-renewable human embryonic stem cell-derived neural stem cell line: Functional engraftment in experimental stroke model. PLoS One 2008;3:e1644.
24. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72.
25. Ito D, Okano H, Suzuki N. Accelerating progress in induced pluripotent stem cell research for neurological diseases. Ann Neurol 2012;72:167-74.
26. Meamar R, Karamali F, Sadeghi HM, Etebari M, Nasr-Esfahani MH, Baharvand H. Toxicity of ecstasy (MDMA) towards embryonic stem cell-derived cardiac and neural cells. Toxicol in vitro 2010;24:1133-8.
27. Meamar R, Dehghani L, Karamali F. Toxicity effects of methamphetamine on embryonic stem cell-derived neuron. J Res Med Sci 2012;17:470-4.
28. Miller RH, Bai L. Translating stem cell therapies to the clinic. Neurosci Lett 2012;519:87-92.
29. Hou L, Hong T. Stem cells and neurodegenerative diseases. Sci China C Life Sci 2008;51:287-94.
30. Jakel RJ, Schneider BL, Svendsen CN. Using human neural stem cells to model neurological disease. Nat Rev Genet 2004;5:136-44.
31. Chu K, Kim M, Jeong SW, Kim SU, Yoon BW. Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia. Neurosci Lett 2003;343:129-33.
32. Chu K, Kim M, Park KI, Jeong SW, Park HK, Jung KH, et al. Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia. Brain Res 2004;1016:145-53.
33. Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC, et al. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 1984;50:147-62.
34. Veizovic T, Beech JS, Stroemer RP, Watson WP, Hodges H. Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Stroke 2001;32:1012-9.
35. Song L, Tuan RS. Trans differentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 2004;18:980-2.
36. Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-Similarities to astrocyte grafts. Proc Natl Acad Sci U S A 1998;95:3908-13.
37. Chen J, Li Y, Wang L, Lu M, Zhang X, Chopp M. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 2001;189:49-57.
38. Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC, et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 2003;92:692-9.
39. Li Y, Chen J, Wang L, Lu M, Chopp M. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 2001;56:1666-72.
40. Carmichael ST. Cellular and molecular mechanisms of neural repair after stroke: Making waves. Ann Neurol 2006;59:735-42.
41. Cramer SC, Koroshetz WJ, Finklestein SP. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents. Stroke 2007;38:1393-5.
42. Rueger MA, Backes H, Walberer M, Neumaier B, Ullrich R, Simard ML, et al. Noninvasive imaging of endogenous neural stem cell mobilization in vivo using positron emission tomography. J Neurosci 2010;30:6454-60.
43. Savitz SI, Chopp M, Deans R, Carmichael ST, Phinney D, Wechsler L. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke 2011;42:825-9.
44. Hicks A, Schallert T, Jolkkonen J. Cell-based therapies and functional outcome in experimental stroke. Cell Stem Cell 2009;5:139-40.
45. Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J, et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000;55:565-9.
46. Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J, et al. Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial. J Neurosurg 2005;103:38-45.
47. Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: A preliminary safety and feasibility study. Cerebrovasc Dis 2005;20:101-7.
48. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005;57:874-82.
49. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY, et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 2010;28:1099-106.
50. Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 2011;134:1790-807.
51. Rabinovich SS, Seledtsov VI, Banul NV, Poveshchenko OV, Senyukov VV, Astrakov SV, et al. Cell therapy of brain stroke. Bull Exp Biol Med 2005;139:126-8.
52. Man Y, Li J, Yang B, Ma J. Vein transplantation using human umbilical cord blood stem cells in the treatment of stroke sequela. Neural Regen Res 2006;1:618-21.
53. Yang QC, Zhang XD, Liang CC, Du Y, Li HW. Functional evaluation of stroke patients 6 months after intrathecal injection of neural stem cells. Chinese J Clin Rehabil 2005;9:208-10.
54. ReNeuron receives: UK ethics committee Favourable Opinion for stroke clinical trial. ReNeuron. Available from: http://www.reneuron.com/news__events/news/ document_196_237.php. [Last accessed on 2009].
55. Prianishnikov VA. On the concept of stem cell and a model of functional-morphological structure of the endometrium. Contracept 1978;18:213-23.
56. Patel AN, Park E, Kuzman M, Benetti F, Silva FJ, Allickson JG. Multipotent menstrual blood stromal stem cells: Isolation, characterization, and differentiation. Cell Transplant 2008;17:303-11.
57. Sanberg PR, Eve DJ, Willing AE, Garbuzova-Davis S, Tan J, Sanberg CD, et al. The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. Cell Transplant 2011;20:85-94.
58. Rodrigues MC, Glover LE, Weinbren N, Rizzi JA, Ishikawa H, Shinozuka K, et al. Toward personalized cell therapies: Autologous menstrual blood cells for stroke. J Biomed Biotechnol 2011;2011:194720.
59. Borlongan CV, Kaneko Y, Maki M, Yu SJ, Ali M, Allickson JG, et al. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev 2010;19:439-52.
60. Zhong Z, Patel AN, Ichim TE, Riordan NH, Wang H, Min WP, et al. Feasibility investigation of allogeneic endometrial regenerative cells. J Transl Med 2009;7:7-15.
61. Boncoraglio GB, Bersano A, Candelise L, Reynolds BA, Parati EA. Stem cell transplantation for ischemic stroke. Cochrane Database Syst Rev 2010;(9):CD007231.